Early stage cancer cell invasion: signaling, biomarkers and therapeutic targeting

Emy Behmoaram1, Krikor Bijian, Tarek A Bismar

  • 1Segal Comprehensive Cancer Center, Lady Davis Institute of the Sir Mortimer B. Davis Jewish General Hospital, Department of Medicine, Faculty of Medicine, McGill University, 3755 Cote Ste-Catherine, Montreal, Canada H3T 1E2.

Insights

Cancer cell invasion involves complex molecular mechanisms regulating motility and migration. Understanding these processes offers potential for new cancer therapeutics and molecular pathology strategies.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Pathology

Background:

  • Cancer cell invasion and metastasis are critical challenges in oncology.
  • Therapeutic management of invasive cancers is hindered by complex signaling pathways driving cell migration.
  • Cancer cell motility is initiated by acquiring autonomous movement, involving focal adhesions, cytoskeleton, and motor proteins.

Purpose of the Study:

  • To review current knowledge on the molecular mechanisms of primary cancer invasion.
  • To highlight potential clinical implications for molecular pathology and cancer therapeutics.

Main Methods:

  • Literature review of current research on cancer cell invasion and migration.
  • Focus on protein complexes, posttranslational modifications, and signaling pathways involved in cell motility.
  • Discussion of clinical implications without exhaustive coverage of basic signaling.

Main Results:

  • Cancer cell invasion is a multistep process regulated by dynamic protein assemblies and posttranslational modifications.
  • Cell shape, polarity, and migration are controlled by concerted molecular mechanisms in response to chemotactic signals.
  • Understanding these mechanisms is key to developing novel cancer treatments.

Conclusions:

  • The molecular intricacies of cancer cell invasion present therapeutic targets.
  • Further research into these pathways can advance molecular pathology and improve cancer treatment strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...